AURX

Nuo Therapeutics, Inc.

USD

Set alert

Price alert · AURX

All alert types
1.30 USD 0.00 0.00%
As of Oct 29, 2026
1.28 Day range 1.28
0.77 52-week range 2.57
YTD
-34.01%
1 year
-42.22%
Open
1.28
Prev close
1.30
Mkt cap
62.96M
Vol
100
Avg vol
4.49K
EPS
-0.04
P/E
0.00
More statistics
Low
1.28
High
1.28

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for AURX has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-10.07 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -37.1×
FY 2016: 0.1×FY 2017: -0.1×FY 2018: -0.6×FY 2019: -2.0×FY 2020: -83.3×FY 2021: -0.0×FY 2022: -19.8×FY 2023: -7.3×FY 2024: -27.3×FY 2025: -37.1×
FY 2016 5y median -19.8× FY 2025
P/S 28.1×
FY 2016: 1.4×FY 2017: 2.6×FY 2018: 0.7×FY 2019: 19.5×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 535×FY 2023: 38.0×FY 2024: 46.6×FY 2025: 28.1×
FY 2016 5y median 38.0× FY 2025
P/B -97.4×
FY 2016: 0.2×FY 2017: 3.9×FY 2018: -11.4×FY 2019: -5.6×FY 2020: -22.4×FY 2021: -0.0×FY 2022: 27.4×FY 2023: 22.3×FY 2024: 124×FY 2025: -97.4×
FY 2016 5y median 22.3× FY 2025
P/FCF -81.8×
FY 2016: -0.3×FY 2017: -0.4×FY 2018: -1.1×FY 2019: -683×FY 2020: -1174×FY 2021: -0.2×FY 2022: -15.9×FY 2023: -7.3×FY 2024: -26.6×FY 2025: -81.8×
FY 2016 5y median -15.9× FY 2025
EV/EBITDA -39.5×
FY 2016: -0.0×FY 2017: -0.1×FY 2018: -0.4×FY 2019: -3.9×FY 2020: -39.6×FY 2021: 0.0×FY 2022: -18.8×FY 2023: -7.3×FY 2024: -26.9×FY 2025: -39.5×
FY 2016 5y median -18.8× FY 2025
EV/Sales 28.1×
FY 2016: 0.1×FY 2017: 1.7×FY 2018: 0.4×FY 2019: 23.2×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 519×FY 2023: 36.9×FY 2024: 46.5×FY 2025: 28.1×
FY 2016 5y median 36.9× FY 2025
FCF Yield -1.2%
FY 2016: -366.9%FY 2017: -257.6%FY 2018: -93.9%FY 2019: -0.1%FY 2020: -0.1%FY 2021: -429.2%FY 2022: -6.3%FY 2023: -13.7%FY 2024: -3.8%FY 2025: -1.2%
FY 2016 5y median -6.3% FY 2025

Profitability

Gross Margin 66.9%
FY 2016: 9.8%FY 2017: -51.3%FY 2018: 88.1%FY 2019: 21.6%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 82.9%FY 2023: 79.3%FY 2024: 77.8%FY 2025: 66.9%
FY 2016 5y median 77.8% FY 2025
Operating Margin -76.0%
FY 2016: -379.7%FY 2017: -2154.4%FY 2018: -109.8%FY 2019: -663.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -2958.2%FY 2023: -520.6%FY 2024: -180.0%FY 2025: -76.0%
FY 2016 5y median -180.0% FY 2025
Net Margin -75.8%
FY 2016: 1019.6%FY 2017: -2077.4%FY 2018: -112.5%FY 2019: -968.9%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -2695.1%FY 2023: -521.2%FY 2024: -170.2%FY 2025: -75.8%
FY 2016 5y median -170.2% FY 2025
ROE 262.6%
FY 2016: 174.0%FY 2017: -3102.0%FY 2018: 1880.6%FY 2019: 278.1%FY 2020: 27.0%FY 2021: 17.4%FY 2022: -138.1%FY 2023: -305.2%FY 2024: -452.3%FY 2025: 262.6%
FY 2016 5y median -138.1% FY 2025
ROIC -408.7%
FY 2016: -63.8%FY 2017: -3188.5%FY 2018: -662.8%FY 2019: -510.8%FY 2020: 73.3%FY 2021: 17.4%FY 2022: -131.4%FY 2023: -244.7%FY 2024: -362.6%FY 2025: -408.7%
FY 2016 5y median -244.7% FY 2025
ROA -136.1%
FY 2016: 154.9%FY 2017: -1051.8%FY 2018: -158.1%FY 2019: -900.6%FY 2020: -91.0%FY 2021: -60.5%FY 2022: -99.3%FY 2023: -168.9%FY 2024: -195.4%FY 2025: -136.1%
FY 2016 5y median -136.1% FY 2025

Growth (YoY)

Revenue 142.7%
FY 2016: -80.8%FY 2017: -67.3%FY 2018: 90.1%FY 2019: -89.3%FY 2020: -100.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 442.1%FY 2024: 124.3%FY 2025: 142.7%
FY 2016 FY 2025
Operating Income -2.4%
FY 2016: 79.7%FY 2017: -85.6%FY 2018: 90.3%FY 2019: 35.6%FY 2020: 61.0%FY 2021: 76.0%FY 2022: -3562.3%FY 2023: 4.6%FY 2024: 22.4%FY 2025: -2.4%
FY 2016 FY 2025
EPS (diluted) -3.7%
FY 2016: 638.1%FY 2017: -145.1%FY 2018: 93.5%FY 2019: 9.8%FY 2020: 91.5%FY 2021: 41.2%FY 2022: -2420.0%FY 2023: 0.3%FY 2024: 32.1%FY 2025: -3.7%
FY 2016 FY 2025
Free Cash Flow 52.2%
FY 2016: 27.6%FY 2017: 55.1%FY 2018: 82.2%FY 2019: 99.5%FY 2020: -136.3%FY 2021: -32.0%FY 2022: -28865.7%FY 2023: 15.7%FY 2024: 24.8%FY 2025: 52.2%
FY 2016 FY 2025

Financial Health

Current Ratio 1.1×
FY 2016: 2.8×FY 2017: 1.3×FY 2018: 0.8×FY 2019: 0.2×FY 2020: 0.2×FY 2021: 0.2×FY 2022: 4.4×FY 2023: 2.3×FY 2024: 1.5×FY 2025: 1.1×
FY 2016 5y median 1.5× FY 2025
Quick Ratio 0.9×
FY 2016: 2.7×FY 2017: 1.2×FY 2018: 0.8×FY 2019: 0.2×FY 2020: 0.2×FY 2021: 0.2×FY 2022: 4.0×FY 2023: 2.0×FY 2024: 1.2×FY 2025: 0.9×
FY 2016 5y median 1.2× FY 2025
Debt / Equity -0.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -3.8×FY 2019: -1.4×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.2×FY 2023: 0.2×FY 2024: 0.3×FY 2025: -0.6×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA -0.0×
FY 2016: 0.4×FY 2017: 0.1×FY 2018: 0.2×FY 2019: -0.6×FY 2020: 0.5×FY 2021: 0.0×FY 2022: 0.6×FY 2023: 0.2×FY 2024: 0.1×FY 2025: -0.0×
FY 2016 5y median 0.1× FY 2025
Interest Coverage -3130×
FY 2016: 0.0×FY 2017: -1436×FY 2018: -38.7×FY 2019: -4.4×FY 2020: -7.8×FY 2021: 0.0×FY 2022: -1579×FY 2023: -1002×FY 2024: 0.0×FY 2025: -3130×
FY 2016 5y median -1002× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31